Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
NCT04594746Phase 4Terminated
- Sponsor
- University of Calgary
- Start
- Feb 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiodarone in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by University of Calgary. Started Feb 2022; status: terminated.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT04594746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04594746.